Compare Expedia Group Inc (EXPE) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expedia Group Inc vs ImmunityBio Inc. Common Stock — how do they compare? Expedia Group Inc trades at $269.5 (market cap $31.07B), while ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B). The key difference: Expedia Group Inc is far larger — about 3× ImmunityBio Inc. Common Stock's market cap, and Expedia Group Inc pays a 0.74% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Expedia Group Inc for 48 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| EXPE | IBRX | |
|---|---|---|
Market Cap | $31.07B | $10.33B |
Volume | 1,305,431 | 11,745,198 |
Sector | Consumer Cyclical | Health |
52-Week High | $339.13 | $11.55 |
52-Week Low | $188.51 | $1.98 |
Typical Hold Time | 48 Days | 0 Days |
Enterprise Value | $29.63B | $10.79B |
Dividend Yield | 0.74% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Expedia Group (EXPE) trades at $270.13, up 3.95% today, with strong earnings beats in recent quarters but facing technical bearish signals. The company shows robust fundamentals with 2025 revenue of $14.73B, net income of $1.29B, and healthy cash flow generation. Recent news highlights competitive threats from AI travel agents and workforce reductions, while analyst consensus remains mixed with a $335.06 price target.
EXPE presents a valuation opportunity with P/E of 16.28 below sector averages, but faces significant headwinds from AI disruption in travel booking. The stock's 199% ROE and consistent earnings outperformance support long-term growth potential, though near-term technical weakness and competitive pressures require careful monitoring.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Expedia Group Inc
Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Read more on EXPE →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
